Jose Iglesias - BNO BE Insider

BNO BE -- Germany Stock  

 0.905  0.00  0.00%

Chief Medical Officer

Dr. Jose Iglesias is Chief Medical Officer of Bionomics Ltd since November 2012. He is a seasoned medical professional with 22 years global experience in the biopharmaceutical industry. Prior to joining Bionomics, he spent six years at Celgene Corporationrationration and its wholly owned subsidiary Abraxis Bioscience as VP of Clinical Development at Celgene with previous roles including CMO and VP of Global Clinical Development and Medical Affairs at Abraxis. Previously, Dr Iglesias worked in several positions at US pharmaceutical giant Eli Lilly over 10 years, including his appointment as Oncology Medical Advisor for the Australia and the Asia Pacific region between 2002 and 2004. A graduate from the Montevideo School of Medicine, Dr Iglesias was published more than 50 times and is an active member of ASCO, AACR and ESMO.
  Executive Since 2012  Ph.D    

Management Efficiency

Entity Summary

BNO BE (BNO) is traded on Berlin Stock Exchange in Germany. and employs 8 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add BNO BE to your portfolio

Top Management

BNO BE Leadership Team
Stephen Birrell, CFO
Jens Mikkelsen, Executive, Ph.D
Melanie Young, CFO
Steve Lydeamore, CFO
Robert Corringham, Executive
Trevor Tappenden, Director
Alan Dunton, Director
Graeme Kaufman, Director, MBA
Peter Turner, Director
Errol Souza, Director, Ph.D
David Wilson, Director
Deborah Rathjen, CEO, Ph.D
Tony Colasin, Executive
Alan Fisher, Director
Jose Iglesias, Executive, Ph.D
Jack Moschakis, Executive
Jonathan Lim, Director

Stock Performance

BNO BE Performance Indicators